HEALTH OF WOMAN. 2020.4(150): 51–56; doi 10.15574/HW.2020.150.51
Romanenko T. G. , Morozova O. V., Sulimenko O. M.
Shupyk National Medical Academy of Postgraduate Education MH of Ukraine, Kiev

The objective: to reduce the frequency and severity of iron deficiency anemia (IDA) in multiple pregnancies by optimizing its prevention, treatment and proving the effectiveness and safety of the therapy.
Materials and methods. 90 pregnant women were under observation. The control group (CG) consisted of 30 pregnant women with one fetus, group I – 30 women with multiple pregnancies who did not use the recommended therapy, group II – 30 women with multiple pregnancies, conducted according to our proposed method.
The effectiveness of therapy was evaluated weekly by subjective evaluation of improvement and according to laboratory parameters of peripheral blood.
General clinical methods included clinical, general blood analysis and determination of serum iron, quantitative determination of the concentration of sulfhydryl groups and lipoproteins in erythrocyte elements of peripheral blood, studied the surface architecture of erythrocyte membranes.
Results. There was a significant reduction in the frequency and severity of IDA in pregnant women of group II in 1.6 times.Diagnosed with a significant increase in the number of discocytes (group I 67.34±0.81; group II 84.53±1.04; p<0.05), a decrease in the number of ellipses (group I 0.99±0.05; group II 0.60±0.05; p<0.05); flat disks (group I 0.87±0.07; group II 0.56±0.03; p<0.05); dome-shaped (I group 2.41±0.14; ІІ group 1.82±0,11; р<0.05) and spherical erythrocytes (І group 4.11±0.12; ІІ group 2.44±0, 13; p<0.05). Significant decrease in the number of transitional forms (group I 3.41±0.31%; group II 2.53±0.21; p<0.05); pre hemolytic (I group 2.41±0.14%; ІІ group 1.44±0.11%; р<0.05) and degenerative forms (І group 1.18±0.14%; ІІ group 0.52±0.03; p<0.05), as well as the ratio of the inner and outer diameters of erythrocytes (group I 66.71±0.91; group II 45.81±0.63; p<0.05). There was a significant increase in the ratio of sulfhydryl groups and lipoproteins in erythrocyte membranes.
Conclusions. The complex composition of the drug Fersinol and Fersinol-Z, taking into account the effective antianemic action, can be considered optimal for the prevention and treatment of iron deficiency in multiple pregnancies and recommended for use in practical health care.
Keywords: multiple pregnancy, iron deficiency anemia, prevention, treatment, Fersinol ampoules, Fersinol-Z capsules.

REFERENCES

1. Wiegersma AM, Dalman C, Lee BK et al. 2019, Sept 18. Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2019.2309; PMid:31532497 PMCid:PMC6751782

2. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011. (WHO/NMH/NHD/MNM/11.1) (http://www.who.int/vmnis/indicators/ haemoglobin_ ru.pdf).

3. Iron Deficiency Anaemia, Assessment, Prevention, and Control. A guide for programme managers. WORLD HEALTH ORGANIZATION. 2001.

4. Dobrokhotova YuE, Bakhareva I.V. 2018. Iron deficiency anemia of pregnant women:prevention and treatment. RMJ. 26(2-1):59- 64.

5. J. Harper. Iron Deficiency Anemia Treatment & Management. Medscape 2016.: https://www.kp.ru/guide/anemija-pri-beremennosti.html

6. Rizaeva LK. 2017. Epidemiologiya rasprostranennosti zhelezodefitsitnoy anemii. International scientific review 2(33):108-109.

7. Savchenko TN, Agaeva MI, Dergacheva IA. 2014. Zhelezodefitsitnaya anemiya kak faktor riska ugrozyi preryivaniya beremennosti. RMZh.

8. Friedrisch JR, Friedrisch BK. 2017. Prophylactic Iron Supplementation in Pregnancy: A Controversial Issue. Biochem Insights. 27:10. https://doi.org/10.1177/1178626417737738; PMid:29123406 PMCid:PMC5661664

9. Protopopova TA. 2012. Iron deficiency anemia and pregnancy. RMJ. Mother and child. RMJ. Mat' i ditya 20(17):862-866.

10. Badfar G, Shohani M, Soleymani A, Azami M. 2017. Maternal anemia during pregnancy and small for gestational age: A systematic review and meta-analysis. J Matern Fetal Neonatal Med. 1:131. https://doi.org/10.1080/14767058.2017.1411477; PMid:29183181

11. Bencaiova G, Burkhardt T, Breymann C. 2012. Anemia prevalence and risk factors in pregnancy. Eur. J. Intern. Med. 23(6):529-533. https://doi.org/10.1016/j.ejim.2012.04.008; PMid:22863430

12. Beucher G, Grossetti E, Simonet T et al. 2011. Iron deficiency anemia and pregnancy Prevention and treatment. J. Gynecol. Obstet. Biol. Reprod. 40(3):185-200. https://doi.org/10.1016/j.jgyn.2011.01.004; PMid:21333465

13. Blindar VN, Zubrihina GN, Matveeva II. 2016. Osnovnyie metabolityi ferrokinetiki v differentsialnoy diagnostike anemicheskogo sindroma. Klinicheskaya laboratornaya diagnostika 61(4):219–223.

14. Ustinov O. 2016. Zalizodefitsytna anemiia: protokol spetsializovanoi medychnoi dopomohy. https://www.umj.com.ua/ article/93084/

15. Turner J, Parsi M, Badireddy M. 2020. Anemia. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK499994/